ClinicalTrials.gg
CompletedNCT06967246Updated May 30, 2025

Effect of Kinesio Taping of Pain, Swelling and Trismus After Mandibular Third Molar Surgery

An interventional study of Kinesio tape and non-elastic tape in KINESIOTAPING, Third Molar Extraction Surgery and Pain, sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. Completed at 1 site in Vietnam. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-30.

Sponsored by University of Medicine and Pharmacy at Ho Chi Minh City · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Sep 2023, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates the effectiveness of kinesio taping in reducing swelling, pain, and trismus complications after wisdom tooth extraction surgery. Patients undergoing bilateral symmetrical extraction of mandibular third molars, Kinesio tape was applied on the study side and placebo tape on the control side. Pain intensity was assessed using the Visual Analog Scale (VAS), swelling was measured using predefined facial landmarks, and mouth opening was recorded using interincisal distance measurements. Data were collected preoperatively (T0) and on the 1st (T1), 2nd (T2), and 3rd (T3) postoperative days.

Read the detailed description

Introduction: Complications following third molar surgery can affect patients' quality of life. Kinesio taping is a simple, non-invasive method with a clear mechanism of action in fluid drainage, one of the strategies for symptom reduction in wisdom tooth extraction surgery. This study evaluates the effectiveness of kinesio taping in reducing swelling, pain, and trismus complications after wisdom tooth extraction surgery.

Methods: A split-mouth, randomized, placebo-controlled clinical trial was conducted on 17 patients indicated bilateral mandibular third molar extraction. Each patient had Kinesio tape applied to one surgical site and a placebo tape to the contralateral side. Pain intensity was assessed using the Visual Analog Scale (VAS), swelling was measured using predefined facial landmarks, and mouth opening was recorded using interincisal distance measurements. Data were collected preoperatively (T0) and on the 1st (T1), 2nd (T2), and 3rd (T3) postoperative days.

02

Conditions studied

  • KINESIOTAPING
  • Third Molar Extraction Surgery
  • Pain
  • Swelling
  • Trismus

Browse trials for

03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's enrollment of 17 is below the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

University of Medicine and Pharmacy at Ho Chi Minh City is the lead sponsor of 127 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients have bilaterally impacted mandibular third molars that are relatively symmetrical and have the same difficulty according to Pell and Gregory's classification, with an angulation difference between the two teeth not exceeding 15°. The angulation of each third molar is measured on a panoramic X-ray as the angle formed between the long axis of the third molar and the adjacent second molar.
  • Patients do not have preoperative symptoms of swelling or pain.
  • Patients agree to participate in the study after receiving a clear explanation and counseling.

Exclusion criteria

Exclusion Criteria:

  • Patients with systemic conditions contraindicating tooth extraction surgery.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
17 participants (actual)

Study arms

  • Experimental
    Study group

    kinesio taping after third molar extraction on 1 side

    Combination Product: Kinesio tape

  • Placebo comparator
    control group

    placebo taping after third molar extraction on the other side

    Combination Product: non-elastic tape

Interventions

  • Combination productKinesio tape

    Kinesio tape applied to one surgical site

  • Combination productnon-elastic tape

    The non-elastic tape with only adhesive properties was used as the placebo tape on the other side

06

What researchers measure

Primary outcomes

  1. post operative pain

    * Pain intensity was evaluated using the Visual Analog Scale (VAS) and the total number of analgesic tablets consumed by the patient. Patients self-assessed their pain levels using VAS during the first 3 days after surgery. * The VAS is a 100 mm long straight segment from 0 (painless) to 100 (unbearable pain).

    Time frame: 1st, 2nd, 3rd post operative days

  2. post operative swelling

    - Preoperative facial measurements were recorded by assessing the lengths of the following segments: * AB (vertical dimension): From the outer canthus (A) to the lowest point of the mandibular angle (B). * CD line (horizontal dimension): from the midpoint of the tragus (C) to the oral commissure (D). * BD line (oblique dimension): from the lowest point of the mandibular angle (B) to the oral commissure (D). On each assessment timepoint: - The patient sat in a 45-degree reclined chair position with the lower jaw in the resting position. Swelling was assessed by re-measuring 3 segments: AB, CD and BD during the first 3 days after surgery.

    Time frame: 1st, 2nd, 3td postoperative day

Secondary outcomes

  1. Number of painkiller tablets:

    record the total number of painkiller tablets taken by the patient and summarize on the 3rd day after surgery.

    Time frame: 1st, 2nd, 3rd post operative days

  2. post operative trismus

    The patient's maximum mouth opening was assessed using a caliper to measure the interincisal distance, rounded to the nearest millimeter

    Time frame: 1st, 2nd, 3td postoperative day

07

Study locations

1 site
  • University of Medicine and Pharmacy at Ho Chi Minh city
    Ho Chi Minh city, 700000, Vietnam
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2023 to primary completion in Jul 2024, 10 months.

Of 3,731 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 10 months is close to that.

Counting every sponsor, half of 3,830 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 26, 2025
First posted
May 13, 2025
StartActual
Sep 1, 2023
Primary completionActual
Jul 31, 2024
CompletionActual
Sep 1, 2024
Last update
May 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06967246
Responsible party
Lam Cu Phong (lecturer, clinical professor, University of Medicine and Pharmacy at Ho Chi Minh City) — Principal investigator
First posted
May 13, 2025
Start date
Sep 1, 2023
Primary completion
Jul 31, 2024
Completion
Sep 1, 2024
Last update
May 30, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion